Cat. No.: DMM-001280
| Status | Age | Sex |
|---|---|---|
|
|
|
| Model Overview | |
|---|---|
| Model Description | These Gck knock-out mice exhibit a decreased insulin secretory response to glucose. They are suitable for use in applications related to the study of maturity-onset diabetes. |
| Strain Name | B6.129P2-Gcktm1Efr/J |
| Background Strain | 129P2/OlaHsd |
| SPF | Yes |
| Research Application | Diabetes |
| Target Information | |
|---|---|
| Target Name | Gck |
| Synonyms | FGQTL3, GK, GLK, Gls006, GLUKA, hexokinase 4, HHF3, HK4, HKIV, Hlb62, HXKP, LGLK, MODY2, PNDM1, RNGK2 |
| Gene ID | 2654 |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.